Published in BMJ Open on October 06, 2017
Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA (1996) 36.04
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA (2001) 19.20
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ (2010) 5.58
Increasing value and reducing waste: addressing inaccessible research. Lancet (2014) 4.83
How important is publication bias? A synthesis of available data. AIDS Educ Prev (1997) 4.67
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev (2012) 4.36
An observational study of orthopaedic abstracts and subsequent full-text publications. J Bone Joint Surg Am (2002) 4.25
Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet (2000) 4.16
The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials (2002) 3.62
Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev (2007) 3.51
Peer-reviewed publication of clinical trials completed for pediatric exclusivity. JAMA (2006) 2.92
External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS One (2007) 2.70
Discrepancies and rates of publication in orthopaedic sports medicine abstracts. Am J Sports Med (2008) 2.57
Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA (2006) 2.53
Abstracts of randomized controlled trials presented at the society for pediatric research meeting: an example of publication bias. Arch Pediatr Adolesc Med (2002) 2.15
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials. Br J Psychiatry (2013) 1.80
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ (2012) 1.58
ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol (2015) 1.44
Assessment of adherence to the CONSORT statement for quality of reports on randomized controlled trial abstracts from four high-impact general medical journals. Trials (2012) 1.42
From conference abstract to full paper: differences between data presented in conferences and journals. FASEB J (2005) 1.39
Out of sight but not out of mind: how to search for unpublished clinical trial evidence. BMJ (2012) 1.28
Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal. Int J Neuropsychopharmacol (2011) 1.19
Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials. Fam Pract (2012) 1.15
Searching for unpublished trials in Cochrane reviews may not be worth the effort. J Clin Epidemiol (2009) 1.10
Quinine for nocturnal leg cramps: a meta-analysis including unpublished data. J Gen Intern Med (1998) 1.08
Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ (2013) 1.07
Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine. Int Clin Psychopharmacol (2007) 1.04
Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLoS Med (2012) 0.99
A benefit-risk assessment of agomelatine in the treatment of major depression. Drug Saf (2011) 0.97
Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther (2004) 0.95
Regulatory agencies hold the key to improving Cochrane reviews of drugs. Cochrane Database Syst Rev (2015) 0.77